Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Porter

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Nature Communications|March 4, 2022
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemiaMiyoung Lee, Jamie A G Hamilton, Ganesh R Talekar, et al.
Genome Medicine|October 16, 2023
Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemiaHope L Mumme, Sunil S Raikar, Swati S Bhasin, et al.
Scientific Reports|July 13, 2022
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12Rae Hunter, Kathleen J Imbach, Chengjing Zhou, et al.
JCI Insight|August 26, 2020
ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genesMarlie H Fisher, Gregory D Kirkpatrick, Brett Stevens, et al.
Aging Cell|January 22, 2021
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgroundsJamie A G Hamilton, Miyoung Y Lee, Rae Hunter, et al.
Experimental Hematology|July 8, 2022
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitorsChengjing Zhou, Rizvan Uluisik, Jesse W Rowley, et al.
Scientific Reports|May 19, 2023
YB1 modulates the DNA damage response in medulloblastomaLeon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Scientific Reports|June 15, 2023
Author Correction: YB1 modulates the DNA damage response in medulloblastomaLeon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Cancer Research|May 31, 2019
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia ProgressionJennifer L Rabe, Lori Gardner, Rae Hunter, et al.
Transplantation and Cellular Therapy|November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell TransplantationLacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Nature Communications|March 4, 2022
Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemiaMiyoung Lee, Jamie A G Hamilton, Ganesh R Talekar, et al.
Genome Medicine|October 16, 2023
Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemiaHope L Mumme, Sunil S Raikar, Swati S Bhasin, et al.
Scientific Reports|July 13, 2022
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12Rae Hunter, Kathleen J Imbach, Chengjing Zhou, et al.
JCI Insight|August 26, 2020
ETV6 germline mutations cause HDAC3/NCOR2 mislocalization and upregulation of interferon response genesMarlie H Fisher, Gregory D Kirkpatrick, Brett Stevens, et al.
Aging Cell|January 22, 2021
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgroundsJamie A G Hamilton, Miyoung Y Lee, Rae Hunter, et al.
Experimental Hematology|July 8, 2022
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitorsChengjing Zhou, Rizvan Uluisik, Jesse W Rowley, et al.
Scientific Reports|May 19, 2023
YB1 modulates the DNA damage response in medulloblastomaLeon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Scientific Reports|June 15, 2023
Author Correction: YB1 modulates the DNA damage response in medulloblastomaLeon F McSwain, Claire E Pillsbury, Ramona Haji-Seyed-Javadi, et al.
Cancer Research|May 31, 2019
IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia ProgressionJennifer L Rabe, Lori Gardner, Rae Hunter, et al.
Transplantation and Cellular Therapy|November 1, 2023
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell TransplantationLacey S Williams, Kirsten M Williams, Nancy Gillis, et al.
Pageof 8